flector Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Flector, and when can generic versions of Flector launch?
Flector is a drug marketed by Ibsa and is included in one NDA.
The generic ingredient in FLECTOR is diclofenac epolamine. There are forty-seven drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the diclofenac epolamine profile page.
Summary for flector
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 7 |
Raw Ingredient (Bulk) Api Vendors: | 25 |
Clinical Trials: | 5 |
Patent Applications: | 103 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for flector |
What excipients (inactive ingredients) are in flector? | flector excipients list |
DailyMed Link: | flector at DailyMed |
Recent Clinical Trials for flector
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Fidia Farmaceutici s.p.a. | Phase 3 |
Fidia Farmaceutici s.p.a. | Phase 1 |
IBSA Institut Biochimique SA | Phase 4 |
Pharmacology for flector
Drug Class | Nonsteroidal Anti-inflammatory Drug |
Mechanism of Action | Cyclooxygenase Inhibitors |
Physiological Effect | Decreased Prostaglandin Production |
Anatomical Therapeutic Chemical (ATC) Classes for flector
Paragraph IV (Patent) Challenges for FLECTOR
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
FLECTOR | Topical Patch | diclofenac epolamine | 1.3% | 021234 | 1 | 2015-06-26 |
US Patents and Regulatory Information for flector
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ibsa | FLECTOR | diclofenac epolamine | SYSTEM;TOPICAL | 021234-001 | Jan 31, 2007 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for flector
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Ibsa | FLECTOR | diclofenac epolamine | SYSTEM;TOPICAL | 021234-001 | Jan 31, 2007 | ⤷ Try a Trial | ⤷ Try a Trial |
Ibsa | FLECTOR | diclofenac epolamine | SYSTEM;TOPICAL | 021234-001 | Jan 31, 2007 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for flector
See the table below for patents covering flector around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Portugal | 86121 | PROCESSO PARA A PREPARACAO DE SAL DE ACIDO 2-{(2,6-DICLOROFENIL)-AMINO}-BENZENO-ACETICO COM UMA BASE ORGANICA CICLICA E DE COMPOSICOES FARMACEUTICAS CONTENDO O MESMO | ⤷ Try a Trial |
Finland | 875023 | ⤷ Try a Trial | |
South Africa | 9402637 | ⤷ Try a Trial | |
Japan | 3526887 | ⤷ Try a Trial | |
Italy | 8622320 | ⤷ Try a Trial | |
Italy | 1228242 | SALE DEL DICLOFENAC CON IDROSSIETILPIRROLIDINA E COMPOSIZIONI FARMACEUTICHE CHE LO CONTENGONO | ⤷ Try a Trial |
>Country | >Patent Number | >Title | >Estimated Expiration |